Friday, February 20, 2026
21 C
Bengaluru

Interesting, Engaving & Relevant

[wpfilebase tag=file id=88 tpl=download-button /]

Inside this Issue

1. Pharma Success Story: Medical Rep to Country Manager by Deepak Sharma
Deepak Sharma shares his story of finding success in Pharma and what it took him to get there.

2. Year-end Performance Reviews: Retrospective or Prospective? by K. Hariram
As the financial year comes to a close and performance reviews are around the bend, how should this important exercise be conducted? 

3. The Five Drivers of Brand Equity by Vivek Hattangadi
A clear formula to audit and increase the perception and recall of your brand in the Doctor’s mind.

4. Case Study: Moving to a Competency-based HR System in Pharma by Diksha Fouzdar
In the wake of an acquisition and FDA warning, a large pharma company decided to completely overhaul its existing HR systems – here is the process and outcome.

Hot this week

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Topics

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...
spot_img

Related Articles

spot_imgspot_img